Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||ET3620 / 1||LA / OT|
Administered by: Other Purchased by: ??
Symptoms: Acute respiratory distress syndrome, Cardiac arrest, Chest X-ray, Cough, Dyspnoea, Pyrexia, COVID-19, SARS-CoV-2 test
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? Yes
Hospitalized? Yes, days:
Write-up: SARS-CoV-2 infection/COVID-19 pneumonia/COVID-19 rapid antigen test became positive; dyspnoea; coughing; fever; acute respiratory distress syndrome; Cardiac arrest; This is a spontaneous report from a contactable physician downloaded from the regulatory authority also received from the agency, The regulatory authority report number is HU-OGYI-289721. A 70-year-old male patient received BNT162B2 (COMIRNATY, strength: 0.3 ml), dose 1 intramuscular, administered in Arm Left on 31Mar2021 (Batch/Lot Number: ET3620) as 1st dose, 0.3 ml single for COVID-19 immunisation. Medical history included diabetic angiopathy, Type II diabetes mellitus, cerebral vascular lesion from 26Nov2013, vertebrobasilar insufficiency from Nov2013, dyslipidaemia and hypertension, all were not ongoing. Concomitant medications included hydrochlorothiazide, irbesartan hydrochloride (CO IRABEL, strength: 150 mg/12,5 mg); ciprofibrate (LIPANOR); rosuvastatin calcium (XETER); insulin human (ACTRAPID HM); amlodipine besilate, perindopril arginine (COVERCARD, strength: 5 mg/5 mg). Clinical course: On 01Apr2021, COVID-19 rapid antigen test became positive (SARS-CoV-2 infection). The patient was transferred to the emergency department due to fever, dyspnoea, and coughing. On 06Apr2021, chest X-ray confirmed COVID-19 pneumonia. Despite the applied therapy (clarithromycin 500 mg (KLACID); Dexamethasone 4 mg; vitamin D 3000 IU; Vitamin C 1000 mg; acetyl salicylic acid 100 mg; Pantoprazol 40 mg; Frontin (alprazolam) 0,25 mg; O2-supplementation, enoxaparin sodium 0,6 ml (CLEXANE), amoxicillin; clavulanic acid 1,2 g (AKTIL INJECTION); methylprednisolone 40 mg (SOLU MEDROL), acute respiratory distress syndrome developed, the patient died on 16Apr2021. Cause of death was cardiac arrest according to the death certificate. Autopsy was not done. All events reported as serious with seriousness criteria of fatal. All events reported requiring hospitalization except event ''cardiac arrest''. Please note that it was unknow whether the reporter was also the patient, thus VAERS Primary Reporter Addl Qualification could not be completed. No follow-up attempts are needed. No further information is expected.; Reported Cause(s) of Death: Cardiac arrest; SARS-CoV-2 infection; Dyspnoea; coughing; fever; acute respiratory distress syndrome
Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166